Scandinavian Tobacco Group's Annual General Meeting - Precautionary measures in relation to coronavirus (COVID-19)
No. 8 2020
Copenhagen, 20 March 2020
Scandinavian Tobacco Group’s Annual General Meeting – Precautionary measures in relation to coronavirus (COVID-19)
Scandinavian Tobacco Group intends to conduct its Annual General Meeting on 26 March 2020 at 4.30 pm as scheduled while following the requirements and recommendations from the authorities in light of the coronavirus.
In order to minimise the risk of spreading the virus and to ensure compliance with the requirement by law that at no time will more than ten people be gathered in the same room/group, we have decided to implement certain precautionary measures. We are taking these measures to ensure the safety of all and hope for your understanding.
Change of venue
The venue of the Annual General Meeting has changed, and the meeting will take place at the company’s offices at Sandtoften 9, 2820 Gentofte, Denmark.
Follow the general meeting via webcast
We encourage our shareholders not to attend the general meeting in person.
Instead of attending in person, our shareholders have the opportunity to follow the general meeting via live webcast transmission on the Investor Portal (available on the website http://investor.st-group.com). The general meeting and the webcast will commence on 26 March 2020 at 4.30 pm.
Read the report from the Board of Directors online
The Report of the Board of Directors on the Company’s activities during the past financial year (item 1 of the agenda) will be made available at the Company’s website (http://investor.st-group.com/corporate-governance/annual-meeting-2020) on 23 March 2020. On the same date it will be sent via email to those shareholders who have provided their email address.
The short presentation with the agenda etc. that will be used during the meeting will also be available on the website (http://investor.st-group.com/corporate-governance/annual-meeting-2020) at the day of the meeting.
Vote by post or by proxy
We encourage our shareholders to vote without being physically present at the general meeting either by postal voting or by granting a proxy to the Board of Directors. You do so by accessing the Investor Portal at http://investor.st-group.com.
Due to the exceptional circumstances, we have extended the deadline for granting proxies and for electronic postal voting on the Investor Portal to 26 March 2020 at 12.00 noon. Please see the notice convening the Annual General Meeting for further information.
If you have already ordered an admission card, please note that you are anyhow able to vote by post and to give a proxy to the Board of Directors instead of attending the meeting.
No catering and only few representatives from Scandinavian Tobacco Group
For those who - irrespective of our recommendations - wish to attend in person, we recommend that you attend unaccompanied. Please arrive no later than at 4.15 pm and line up outside the building while keeping 2 meters distance to others.
Please also note that this year we will not have catering at the general meeting.
To reduce the risk of spreading the infection as much as possible, the only representatives of Scandinavian Tobacco Group's Board of Directors and Management will be the Vice-chairman of the Board of Directors Henrik Brandt and CEO Niels Frederiksen. To ensure that no more than 10 people are present in the same room, you may be directed to a separate room and have to follow the general meeting via video from there.
Shareholders attending the general meeting are strongly requested to follow the hygiene instructions from the Danish Health Authority (see www.sst.dk) and WHO: Please keep good hand hygiene (i.e. use a hand sanitizer/wash hands upon arrival) and remember to cough/sneeze into paper tissues or the crook of the elbow.
We are closely following the authorities’ recommendations
We are closely following the authorities’ recommendations and urge all shareholders to follow the instructions of the Danish Health Authority (see www.sst.dk), including the strong recommendation to stay home for 14 days if you have returned from travel abroad (see www.um.dk), if you have been in contact with infected persons or if you experience any of the described symptoms (fever, cough or troubled breathing).
Scandinavian Tobacco Group A/S
The Board of Directors
For further information, please contact:
Investors: Torben Sand, Head of Investor Relations,
phone: +45 5084 7222 or email@example.com
Media: Simon Mehl Augustesen, Director of Group Communications,
phone: +1 484-379-8725 or firstname.lastname@example.org
About Scandinavian Tobacco Group
Scandinavian Tobacco Group A/S is a world leading manufacturer of cigars and pipe tobacco with an annual production of four billion cigars and 5,000 tonnes of pipe and fine-cut tobacco.
The Group holds market-leading positions in several categories and has a portfolio of more than 200 global and local brands.
Scandinavian Tobacco Group has its headquarter in Copenhagen, Denmark – and employs approximately 11,000 people in Europe, the US, Canada, Australia, New Zealand, the Dominican Republic, Honduras, Nicaragua, Indonesia and Sri Lanka. For more information please visit www.st-group.com
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Nordisk næringsliv fokuserer på innovasjon og forbedring av kundeopplevelsen27.1.2020 10:00:00 CET | Pressemelding
Rapporten ISG Provider Lens™ viser at selskaper i regionen henvender seg til leverandører av digitale forretningstjenester for hjelp med analyse, kunstig intelligens og andre teknologier STOCKHOLM i Sverige, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Næringslivet i de nordiske landene fokuserer på å forbedre kundeopplevelsen og innovasjonen, og kontakter leverandører av digitale forretningstjenester for å nå målene sine. Dette viser en ny rapport som ble publisert i dag av Information Services Group ( ISG ) (Nasdaq: III ), et verdensledende teknologisk forsknings- og rådgivningsselskap. Rapporten 2019-2020 ISG Provider Lens™ Digital Business – Solutions and Service Partners for Norden viser at bedrifter i regionen omfavner teknologier som dataanalyse, kunstig intelligens, tingenes internett og blokkjeder for å levere kvalitetstjenester til kundene sine og for å skille ut seg fra konkurrenter. «Nordiske bedrifter søker transformasjonstjenester fra IT-leverandører for ikke bare å bli veiledet gje
UPM commits to UN Business Ambition for 1.5°C to mitigate climate change27.1.2020 10:00:00 CET | Press release
(UPM, Helsinki, 27 January 2020 at 11:00 EET) – UPM commits to the United Nations Global Compact’s Business Ambition for 1.5°C, joining leading companies in a promise to pursue science-based measures to limit global temperature rise to 1.5°C. UPM will strive to mitigate climate change and drive value creation through innovating novel products, committing to a 65% CO2 emission reduction and by practicing sustainable forestry. The 1.5°C ambition is a response to increasing concern about the severe consequences of a failure to stop global warming. UPM is among the first global forest industry companies making this commitment. “UPM has a unique opportunity to make a positive impact and contribute to mitigating climate change by tangible actions. We innovate climate-positive products and turn them into growing businesses. At the same time, we limit risks from climate mitigation policies and physical impacts of changing climate. This is important for the long-term value of the company,” says
Valmet to supply a board machine rebuild to Umka in Serbia27.1.2020 10:00:00 CET | Press release
Valmet Oyj’s press release on January 27, 2020 at 11:00 a.m . EET Valmet will supply a board machine rebuild to Umka Cardboard Mill in Serbia. The main target of the rebuild is to increase the customer’s production capacity. The start-up of the rebuilt paper machine PM 1 is scheduled for the second half of 2021. The order is included in Valmet's orders received of the fourth quarter 2019. The value of the order will not be disclosed. The total value of an order of this type is typically around EUR 15-20 million. "This rebuild is one of the most important strategic decisions we have made in the course of 80 years long history of the mill. We are pleased that this project is going to be completed by Valmet, a global leader in the supply of process technology in the paper industry. I strongly believe in the success and bright future of Umka Cardboard Mill, with planned capacity of over 200,000 tonnes, further quality improvements and wider product portfolio,” says Milos Ljusic, Managing D
Nordic Enterprises Focus on Innovation and Improving Customer Experience27.1.2020 10:00:00 CET | Press release
ISG Provider Lens™ report finds companies in the region turning to digital business services providers for help with analytics, artificial intelligence and other technologies STOCKHOLM, Sweden, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Enterprises in the Nordic countries are focused on improving customer experience and enhancing innovation, and they are turning to digital business service providers to achieve their goals, according to a new report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm. The 2019-2020 ISG Provider Lens™ Digital Business – Solutions and Service Partners Report for the Nordics finds enterprises in the region embracing technologies such as data analytics, artificial intelligence, the Internet of Things and blockchain to deliver quality services to their customers and to differentiate themselves from competitors. “Nordic enterprises are seeking transformation services from IT providers to not only ta
Nordiska företag fokuserar på innovation och förbättrar kundupplevelsen27.1.2020 10:00:00 CET | Pressemelding
Rapport från ISG Provider Lens™ visar att företag i regionen vänder sig till leverantörer av digitala företagstjänster för hjälp med analys, artificiell intelligens och annan teknik STOCKHOLM, Sverige, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Företag i Norden är inriktade på att förbättra kundupplevelse och innovation, och de vänder sig till leverantörer av digitala företagstjänster för att uppnå sina mål, enligt en ny rapport publicerad idag av Information Services Group ( ISG ) (Nasdaq: III ), ett ledande företag inom global teknikforskning och -rådgivning. Rapporten Digital verksamhet – lösningar och servicepartners2019–2020 från ISG Provider Lens™ för Norden visar att företag i regionen anammar teknik som dataanalys, artificiell intelligens, sakernas internet och blockkedja för att leverera kvalitetstjänster till sina kunder och för att utmärka sig bland konkurrenterna. ”De nordiska företagen söker transformationstjänster från IT-leverantörer för att inte bara ta dem genom sina digitala r
Roche submits supplemental Biologics License Application to the FDA for Tecentriq in combination with Avastin for the most common form of liver cancer27.1.2020 07:00:00 CET | Press release
·Application is being reviewed under FDA’s Real-Time Oncology Review pilot programme Basel, 27 January 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the completion of a supplemental Biologics License Application (sBLA) submission to the US Food and Drug Administration (FDA) for Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab), for the treatment of people with unresectable hepatocellular carcinoma (HCC) who have not received prior systemic therapy. The FDA is reviewing the application under the Real-Time Oncology Review pilot programme, which aims to explore a more efficient review process to ensure safe and effective treatments are available to patients as early as possible. In July 2018, the FDA granted Breakthrough Therapy Designation for Tecentriq in combination with Avastin in HCC based on data from an ongoing Phase Ib trial. “Liver cancer is the most rapidly increasing cause of cancer-related death in the United States. In the IMbrave150 study, Tece